Davidson Investment Advisors increased its holdings in shares of Exelon Corporation (NASDAQ:EXC – Free Report) by 1.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 395,160 shares of the company’s stock after acquiring an additional 3,992 shares during the quarter. Davidson Investment Advisors’ holdings in Exelon were worth $17,158,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. Edgestream Partners L.P. raised its stake in shares of Exelon by 354.9% in the first quarter. Edgestream Partners L.P. now owns 193,388 shares of the company’s stock valued at $8,911,000 after buying an additional 150,876 shares during the period. Arizona State Retirement System raised its stake in shares of Exelon by 3.6% in the first quarter. Arizona State Retirement System now owns 294,857 shares of the company’s stock valued at $13,587,000 after buying an additional 10,176 shares during the period. Cerity Partners LLC raised its stake in shares of Exelon by 14.9% in the first quarter. Cerity Partners LLC now owns 485,968 shares of the company’s stock valued at $22,393,000 after buying an additional 63,009 shares during the period. Zurich Insurance Group Ltd FI bought a new stake in shares of Exelon in the first quarter valued at $47,789,000. Finally, Intech Investment Management LLC raised its stake in shares of Exelon by 24.6% in the first quarter. Intech Investment Management LLC now owns 44,576 shares of the company’s stock valued at $2,054,000 after buying an additional 8,809 shares during the period. 80.92% of the stock is currently owned by institutional investors.
Exelon Trading Up 0.9%
Shares of EXC stock opened at $47.83 on Thursday. The company has a quick ratio of 0.85, a current ratio of 0.95 and a debt-to-equity ratio of 1.66. The business has a 50-day moving average price of $44.55 and a two-hundred day moving average price of $44.39. Exelon Corporation has a 12-month low of $35.94 and a 12-month high of $48.11. The firm has a market cap of $48.31 billion, a P/E ratio of 18.19, a price-to-earnings-growth ratio of 2.93 and a beta of 0.40.
Exelon Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Monday, August 11th were issued a dividend of $0.40 per share. The ex-dividend date was Monday, August 11th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.3%. Exelon’s dividend payout ratio is 60.84%.
Analysts Set New Price Targets
Several equities analysts have recently weighed in on the company. Weiss Ratings reiterated a “buy (b-)” rating on shares of Exelon in a research report on Wednesday, October 8th. Barclays lifted their price target on Exelon from $48.00 to $52.00 and gave the company an “overweight” rating in a research report on Tuesday. Morgan Stanley reduced their price target on Exelon from $50.00 to $49.00 and set an “equal weight” rating for the company in a research report on Thursday, September 25th. KeyCorp lifted their price target on Exelon from $37.00 to $42.00 and gave the company an “underweight” rating in a research report on Wednesday. Finally, Jefferies Financial Group set a $57.00 price target on Exelon in a research report on Wednesday. Six research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Exelon has an average rating of “Hold” and a consensus price target of $50.10.
View Our Latest Stock Analysis on Exelon
Exelon Profile
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Featured Stories
- Five stocks we like better than Exelon
- Why Invest in 5G? How to Invest in 5G Stocks
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What Is WallStreetBets and What Stocks Are They Targeting?
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.